×
Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

BioLineRx Retained Earnings (Accumulated Deficit) 2012-2024 | BLRX

BioLineRx retained earnings (accumulated deficit) from 2012 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  
BioLineRx Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024 $-400
2023 $-391
2022 $-330
2021 $-305
2020 $-278
2019 $-248
2018 $-223
2017 $-200
2016 $-175
2015 $-159
2014 $-145
2013 $-134
2012 $-119
2011 $-96
BioLineRx Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-12-31 $-400
2024-09-30 $-397
2024-06-30 $-391
2024-03-31 $-391
2023-12-31 $-391
2023-09-30 $-377
2023-06-30 $-361
2023-03-31 $-342
2022-12-31 $-330
2022-09-30 $-324
2022-06-30 $-317
2022-03-31 $-310
2021-12-31 $-305
2021-09-30 $-301
2021-06-30 $-295
2021-03-31 $-288
2020-12-31 $-278
2020-09-30 $-266
2020-06-30 $-261
2020-03-31 $-255
2019-12-31 $-248
2019-09-30 $-238
2019-06-30 $-234
2019-03-31 $-229
2018-12-31 $-223
2018-09-30 $-217
2018-06-30 $-211
2018-03-31 $-206
2017-12-31 $-200
2017-09-30 $-192
2017-06-30 $-185
2017-03-31 $-180
2016-12-31 $-175
2016-09-30 $-171
2016-06-30 $-167
2016-03-31 $-163
2015-12-31 $-159
2015-09-30 $-156
2015-06-30 $-154
2015-03-31 $-149
2014-12-31 $-145
2014-09-30 $-143
2014-06-30 $-153
2014-03-31 $-147
2013-12-31 $-134
2013-09-30 $-139
2013-06-30 $-131
2013-03-31 $-125
2012-12-31 $-119
2012-09-30 $-107
2012-06-30 $-101
2012-03-31 $-104
2011-12-31 $-96
2011-09-30 $-95
2011-06-30 $-101
2011-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.010B $0.029B
Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company's portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040, for treatment of patients following a myocardial infarction, BL-5010 for non-surgical removal of skin lesions, BL-1021 for neuropathic pain and BL-7040 for treating Inflammatory Bowel Disease. In addition, BioLineRx has many products in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $95.045B 37.51
Zoetis (ZTS) United States $66.334B 25.11
Takeda Pharmaceutical (TAK) Japan $46.806B 10.36
Daiichi Sankyo, - (DSNKY) Japan $41.678B 25.40
Summit Therapeutics (SMMT) United States $18.154B 0.00
Sandoz Group AG (SDZNY) Switzerland $17.706B 0.00
Merck (MKKGY) Germany $17.202B 14.23
Astellas Pharma (ALPMY) Japan $16.920B 11.99
Shionogi (SGIOY) Japan $14.087B 0.00
United Therapeutics (UTHR) United States $12.788B 11.57
Neurocrine Biosciences (NBIX) United States $10.030B 30.82
IPSEN (IPSEY) France $8.640B 0.00
Orion OYJ (ORINY) Finland $7.957B 22.55
Madrigal Pharmaceuticals (MDGL) United States $6.661B 0.00
Stevanato Group S.p.A (STVN) Italy $6.620B 42.04
Corcept Therapeutics (CORT) United States $6.567B 50.19
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.547B 11.36
Grifols, S.A (GRFS) Spain $4.868B 0.00
Ionis Pharmaceuticals (IONS) United States $4.515B 0.00
Soleno Therapeutics (SLNO) United States $3.209B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.831B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.747B 11.15
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.281B 14.15
Recursion Pharmaceuticals (RXRX) United States $2.211B 0.00
Hypermarcas (HYPMY) Brazil $2.128B 8.40
NewAmsterdam Pharma (NAMS) Netherlands $1.794B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.638B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.546B 0.00
Guardian Pharmacy Services (GRDN) United States $1.526B 0.00
ARS Pharmaceuticals (SPRY) United States $1.460B 186.00
Evotec AG (EVO) Germany $1.278B 0.00
Indivior (INDV) United States $1.242B 5.40
Ocular Therapeutix (OCUL) United States $1.162B 0.00
Ardelyx (ARDX) United States $1.148B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.064B 43.06
Dyne Therapeutics (DYN) United States $0.928B 0.00
AleAnna (ANNA) United States $0.878B 0.00
Collegium Pharmaceutical (COLL) United States $0.868B 4.61
Harrow (HROW) United States $0.855B 0.00
Enliven Therapeutics (ELVN) United States $0.810B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.776B 0.00
Xencor (XNCR) United States $0.683B 0.00
Cronos Group (CRON) Canada $0.682B 0.00
Bioventus (BVS) United States $0.641B 16.64
Xeris Biopharma Holdings (XERS) United States $0.633B 0.00
KalVista Pharmaceuticals (KALV) United States $0.597B 0.00
Organogenesis (ORGO) United States $0.535B 0.00
Savara (SVRA) United States $0.520B 0.00
Akebia Therapeutics (AKBA) United States $0.487B 0.00
Relay Therapeutics (RLAY) United States $0.456B 0.00
Elite Pharmaceuticals (ELTP) United States $0.450B 0.00
USANA Health Sciences (USNA) United States $0.448B 9.13
Theravance Biopharma (TBPH) Cayman Islands $0.431B 0.00
Siga Technologies (SIGA) United States $0.428B 7.30
Tourmaline Bio (TRML) United States $0.411B 0.00
Verve Therapeutics (VERV) United States $0.408B 0.00
Zevra Therapeutics (ZVRA) United States $0.387B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.353B 0.00
Altimmune (ALT) United States $0.350B 0.00
Oruka Therapeutics (ORKA) United States $0.345B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.301B 17.93
Heron Therapeutics (HRTX) United States $0.280B 0.00
CytoDyn (CYDY) United States $0.251B 0.00
Aquestive Therapeutics (AQST) United States $0.248B 0.00
Avita Medical (RCEL) United States $0.243B 0.00
ProKidney (PROK) United States $0.231B 0.00
OmniAb (OABI) United States $0.219B 0.00
Nature's Sunshine Products (NATR) United States $0.218B 25.70
Esperion Therapeutics (ESPR) United States $0.188B 23.75
MediWound (MDWD) Israel $0.185B 0.00
Wellgistics Health (WGRX) United States $0.171B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Nanobiotix S.A (NBTX) France $0.155B 0.00
Journey Medical (DERM) United States $0.144B 0.00
Profound Medical (PROF) Canada $0.144B 0.00
Protara Therapeutics (TARA) United States $0.143B 0.00
4D Molecular Therapeutics (FDMT) United States $0.142B 0.00
Inhibikase Therapeutics (IKT) United States $0.141B 0.00
Regulus Therapeutics (RGLS) United States $0.136B 0.00
Aldeyra Therapeutics (ALDX) United States $0.131B 0.00
Korro Bio (KRRO) United States $0.131B 0.00
Lyell Immunopharma (LYEL) United States $0.128B 0.00
Aclaris Therapeutics (ACRS) United States $0.123B 0.00
Larimar Therapeutics (LRMR) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Nektar Therapeutics (NKTR) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.118B 36.33
Champions Oncology (CSBR) United States $0.110B 18.11
Enanta Pharmaceuticals (ENTA) United States $0.109B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.101B 0.00
OptiNose (OPTN) United States $0.093B 0.00
Lexeo Therapeutics (LXEO) United States $0.090B 0.00
Galectin Therapeutics (GALT) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Cardiol Therapeutics (CRDL) Canada $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.079B 0.00
VAXART, INC (VXRT) United States $0.078B 0.00
Context Therapeutics (CNTX) United States $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.074B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.074B 0.00
Unicycive Therapeutics (UNCY) United States $0.072B 0.00
Cassava Sciences (SAVA) United States $0.070B 0.00
Achieve Life Sciences (ACHV) Canada $0.069B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.066B 0.00
Vivani Medical (VANI) United States $0.063B 0.00
Fractyl Health (GUTS) United States $0.060B 0.00
Pyxis Oncology (PYXS) United States $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Metagenomi (MGX) United States $0.057B 0.00
Acrivon Therapeutics (ACRV) United States $0.057B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.056B 0.00
Nutriband (NTRB) United States $0.056B 0.00
Inotiv (NOTV) United States $0.055B 0.00
PMV Pharmaceuticals (PMVP) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.050B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.047B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.045B 0.00
Dominari Holdings (DOMH) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Karyopharm Therapeutics (KPTI) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
NRx Pharmaceuticals (NRXP) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
FibroGen (FGEN) United States $0.029B 0.00
VYNE Therapeutics (VYNE) United States $0.028B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
DURECT (DRRX) United States $0.023B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Enlivex Therapeutics (ENLV) Israel $0.018B 0.00
Mannatech (MTEX) United States $0.018B 7.14
Natural Alternatives (NAII) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioVie (BIVI) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
Mangoceuticals (MGRX) United States $0.013B 0.00
MEI Pharma (MEIP) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.42
Scienture Holdings (SCNX) United States $0.011B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Relmada Therapeutics (RLMD) United States $0.010B 0.00
Cosmos Health (COSM) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 2.68
Nuvilex (PMCB) United States $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Petros Pharmaceuticals (PTPI) United States $0.002B 0.00
CERo Therapeutics Holdings (CERO) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00